Systemic lupus erythematosus (SLE) is the most common form of lupus — it’s the type that 7 in 10 people with lupus have. It's what most people mean when they say "lupus." Experts don’t know what ...

Within the 48-week treatment window, the Bruton’s tyrosine kinase (BTK) inhibitor triggered a 57.1% improvement in patients’ ...

Colombia and Brazil had the highest prevalence and incidence of systemic lupus erythematosus (SLE), a new investigation found. A new analysis of low- and middle-income countries suggests that cases of ...

Orelabrutinib demonstrated outstanding efficacy and well-tolerated safety profile in patients with SLE who had received 48 weeks of treatment in the phase IIb study. A total of 187 patients were ...

Critically ill patients with systemic lupus erythematosus show reduced ICU survival, driven largely by renal dysfunction, ...

Objective Delivery of a small for gestational age (SGA) infant is a common pregnancy complication among women with SLE.

A new study outlining the experiences of women with systemic lupus erythematosus (SLE) finds many women feel their initial symptoms are downplayed by providers, leading to costly delays in diagnosis.

A recent review highlights melatonin's potential in diagnosing and treating systemic lupus erythematosus (SLE). Research indicates lower serum melatonin levels in SLE patients, suggesting diagnostic ...